Wf. Lau et al., POTENTIATION OF BETA-ADRENOCEPTOR AGONIST MEDIATED-LIPOLYSIS BY CHOLESTEROL-DERIVED OXYSTEROLS, Biochemistry and molecular biology international, 35(6), 1995, pp. 1349-1358
Cholesterol-derived oxysterols such as cholestanol, cholestanone and c
oprostanone were able to potentiate epinephrine-induced lipolysis in i
ntact rat adipocytes but not cholesterol. The relative potency of the
oxysterols followed the sequence: cholestanone greater than or equal t
o coprostanone > cholestanol. Cholestanone was selected to study its m
ode of action on epinephrine-induced lipolysis. A sustained increase i
n the level of cAMP was observed in adipocytes incubated with both cho
lestanone and epinephrine compared to a transient peaking of cAMP in a
dipocytes incubated with epinephrine alone. Binding assays using [I-12
5]cyanopindolol (beta-adrenergic receptor antagonist) showed that chol
estanone could increase the binding affinity of [I-125]-cyanopindolol
to beta-adrenergic receptors on rat adipocyte ghost membranes without
affecting the total number of binding sites. The results suggest that
cholestanone exerts its potentiation effect by facilitating the bindin
g of beta-adrenergic agonist to its receptor.